APF
NVAX icon

Alaska Permanent Fund’s Novavax NVAX Stock Holding History

Alaska Permanent Fund’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$555K Hold
54,000
– – 0.01% 313
2022
Q3 		$983K Hold
54,000
– – 0.02% 293
2022
Q2 		$2.78M Buy
+54,000
New +$2.8M 0.04% 98

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alaska Permanent Fund's NVAX Position: Q4 2022 in Review

Alaska Permanent Fund held its Novavax (NVAX) position steady in Q4 2022 at 54,000 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #313.

Alaska Permanent Fund first reported a position in NVAX in Q2 2022 and has held it in 3 quarters since. The position peaked at $2.78M in Q2 2022. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Alaska Permanent Fund held 54,000 shares of Novavax worth $555K as of Q4 2022.
  • Alaska Permanent Fund left its Novavax share count unchanged in Q4 2022.
  • Novavax made up 0.01% of Alaska Permanent Fund's portfolio in Q4 2022, its #313 holding.
  • Alaska Permanent Fund first reported a position in Novavax in Q2 2022 and has held it in 3 quarters since.
  • Alaska Permanent Fund's Novavax position peaked at $2.78M in Q2 2022.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Alaska Permanent Fund's 13F filing for Q4 2022, filed 8 Feb 2023.